Option Care Health (NASDAQ:OPCH) Shares Gap Up - Time to Buy?

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report)'s stock price gapped up before the market opened on Thursday . The stock had previously closed at $29.31, but opened at $30.43. Option Care Health shares last traded at $30.01, with a volume of 177,273 shares trading hands.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. The Goldman Sachs Group downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $38.00 to $27.00 in a report on Monday, November 4th. JMP Securities reissued a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. JPMorgan Chase & Co. increased their price target on Option Care Health from $38.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday. Finally, Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $32.25.

Option Care Health Stock Up 1.1 %

The firm has a market cap of $5.16 billion, a price-to-earnings ratio of 25.49, a PEG ratio of 2.11 and a beta of 1.31. The business has a fifty day simple moving average of $24.26 and a 200 day simple moving average of $27.80. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Buying and Selling

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now directly owns 326,334 shares of the company's stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Westfield Capital Management Co. LP grew its holdings in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock valued at $203,204,000 after buying an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. boosted its position in shares of Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company's stock valued at $1,559,000 after acquiring an additional 25,905 shares during the last quarter. Graypoint LLC purchased a new stake in shares of Option Care Health in the fourth quarter valued at about $1,161,000. Victory Capital Management Inc. increased its position in Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock worth $50,756,000 after purchasing an additional 1,585,818 shares during the last quarter. Finally, Barclays PLC raised its stake in Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company's stock worth $9,708,000 after purchasing an additional 199,454 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.